An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease
Recruiting
N/A
Interventional Study
Sickle Cell Disease
Sickle Beta Zero Thalassemia
Sickle B+ Thalassemia
Sickle Cell Hemoglobin C
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 12 – 21
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 40 (estimated)
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The primary objective of this study is to evaluate a potential behavioral intervention (MED-Go app). To meet this objective, the researchers will conduct a pilot randomized controlled trial to test the feasibility and acceptability of MED-Go app in adolescents and young adults (AYA) with sickle cell disease (SCD). The long-term goal of this research is to promote medication adherence behavior and …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 12-21 years old
* Any sickle cell disease genotype
* On steady state of hydroxyurea for 2 months
* Own of have access to a smartphone during the study period
Exclusion Criteria:
* Recent hospitalizations within the past 7 days
Contacts